论文部分内容阅读
目的探讨乳酸菌片联合复方胃蛋白酶散治疗小儿肺炎继发性腹泻的临床治疗效果。方法选取我院儿科共收治的120例肺炎继发性腹泻儿童住院患者,随机分为观察组和对照组,每组各60例,两组均按常规使用抗生素和对症治疗,对照组在常规治疗基础上加用口服复方乳酸菌胶囊。治疗组在对照组治疗基础上加服复方胃蛋白酶散,比较两组疗效。结果治疗组和对照组患儿的4d治愈率分别为95.00%(57/60)、71.67%(43/60),治疗组的治愈率明显高于对照组,差异有统计学意义(P<0.05)。两组治疗过程中均未发生不良反应。结论乳酸菌片与复方胃蛋白酶散治疗小儿肺炎继发性腹泻具有口感好、优势互补、疗效确切、安全及无不良反应等优点,值得临床推广使用。
Objective To investigate the clinical efficacy of lactic acid bacteria tablets combined with pepsin in the treatment of secondary diarrhea in children with pneumonia. Methods A total of 120 hospitalized children with pneumonia secondary diarrhea were selected and treated in our pediatric department. All patients were randomly divided into observation group and control group, 60 cases in each group. Antibiotics and symptomatic treatment were used in both groups. Conventional treatment Based on the use of oral compound lactic acid bacteria capsules. Treatment group in the control group on the basis of treatment plus compound pepsin powder, the two groups were compared. Results The 4d cure rates in the treatment group and the control group were 95.00% (57/60) and 71.67% (43/60), respectively. The cure rate in the treatment group was significantly higher than that in the control group (P <0.05 ). No adverse reactions occurred in both groups during the treatment. Conclusion lactic acid bacteria tablets and pepsin complex treatment of secondary pneumonia in children with good taste, complementary advantages, the exact effect, safety and no adverse reactions, etc., worthy of clinical promotion and use.